---
schema_version: "secwatch.filing_event.v1"
accession: "0001551152-26-000013"
form_type: "8-K"
ticker: "ABBV"
cik: "0001551152"
company_name: "AbbVie Inc."
filed_at: "2026-04-29T23:59:59+00:00"
generated_at: "2026-05-15T01:46:39.328008+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# AbbVie Q1 adjusted EPS $2.65 (+7.7%), revenue $15.0B (+12.4%); raises FY2026 guidance

## Summary
- GAAP diluted EPS $0.39, down 45.8%; adjusted EPS $2.65, up 7.7%, with $0.41 IPR&D headwind.
- Net revenue $15.002B, +12.4% reported / +10.3% operational; immunology portfolio $7.290B (+16.4%).
- Skyrizi $4.483B (+30.9%), Rinvoq $2.119B (+23.3%), Humira $688M (-38.6%); neuroscience +26%.
- FY2026 adjusted EPS guidance raised to $14.08-$14.28 from $13.96-$14.16.
- FDA CRL for trenibotulinumtoxinE on manufacturing; no safety/efficacy issues; expects prompt refiling.

## SEC filing metadata
- accession: 0001551152-26-000013
- form_type: 8-K
- ticker: ABBV
- cik: 0001551152
- company_name: AbbVie Inc.
- filed_at: 2026-04-29T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000013/0001551152-26-000013-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000013/abbv-20260429.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001551152-26-000013
- JSON: https://secwatch.observer/filing/0001551152-26-000013.json
- Plain text: https://secwatch.observer/filing/0001551152-26-000013.txt

## Key facts
- Earnings Releases
  AbbVie Inc. reported the first quarter ended March 31, 2026 results: revenue $15.002 billion, EPS $0.39. Guidance raised.
  - Period: the first quarter ended March 31, 2026
  - Revenue: $15.002 billion
  - EPS: $0.39
  - Guidance: raised
  - Result: reported results
  source text: Delivers First-Quarter Net Revenues of $15.002 Billion, an Increase of 12.4 Percent on a Reported Basis or 10.3 Percent on an Operational Basis
  evidence_url: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000013/0001551152-26-000013-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.